OSAM
BPMC

O'Shaughnessy Asset Management’s Blueprint Medicines BPMC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,123
Closed -$528K – 2567
2025
Q2 		$528K Buy
4,123
+777
+23% +$80.7K ﹤0.01% 1350
2025
Q1 		$296K Buy
3,346
+153
+5% +$14.9K ﹤0.01% 1592
2024
Q4 		$278K Sell
3,193
-373
-10% -$34.2K ﹤0.01% 1578
2024
Q3 		$316K Buy
3,566
+297
+9% +$29.5K ﹤0.01% 1458
2024
Q2 		$352K Buy
3,269
+298
+10% +$29.8K ﹤0.01% 1286
2024
Q1 		$282K Buy
2,971
+573
+24% +$49.1K ﹤0.01% 1345
2023
Q4 		$221K Buy
+2,398
New +$155K ﹤0.01% 1361
2022
Q2 		– Sell
-4,214
Closed -$269K – 1267
2022
Q1 		$269K Sell
4,214
-12
-0.3% -$861 ﹤0.01% 938
2021
Q4 		$453K Sell
4,226
-159
-4% -$16.6K 0.01% 729
2021
Q3 		$452K Buy
4,385
+858
+24% +$79.9K 0.01% 690
2021
Q2 		$310K Sell
3,527
-35
-1% -$3.21K 0.01% 848
2021
Q1 		$346K Sell
3,562
-53
-1% -$5.29K 0.01% 732
2020
Q4 		$405K Buy
+3,615
New +$381K 0.01% 579
2020
Q1 		– Sell
-55
Closed -$4K – 1347
2019
Q4 		$4K Buy
+55
New +$4.12K ﹤0.01% 1493

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

O'Shaughnessy Asset Management's BPMC Position: Q3 2025 in Review

O'Shaughnessy Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 4,123 shares — an estimated $528K sold.

O'Shaughnessy Asset Management first reported a position in BPMC in Q4 2019 and held it in 14 quarters. The position peaked at $528K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • O'Shaughnessy Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 4,123 Blueprint Medicines shares in Q3 2025, an estimated $528K.
  • O'Shaughnessy Asset Management first reported a position in Blueprint Medicines in Q4 2019 and held it in 14 quarters.
  • O'Shaughnessy Asset Management's Blueprint Medicines position peaked at $528K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.